دورية أكاديمية

The senescent secretome drives PLVAP expression in cultured human hepatic endothelial cells to promote monocyte transmigration.

التفاصيل البيبلوغرافية
العنوان: The senescent secretome drives PLVAP expression in cultured human hepatic endothelial cells to promote monocyte transmigration.
المؤلفون: Wilkinson AL; Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK., Hulme S; Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK., Kennedy JI; Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK., Mann ER; Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK., Horn P; Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK., Shepherd EL; College of Health and Life Sciences, Aston University, Birmingham B4 7ET, UK., Yin K; University of Cambridge, Cancer Research UK Cambridge Institute, Robinson Way, Cambridge CB2 0RE, UK., Zaki MYW; Department of Biochemistry, Faculty of Pharmacy, Minia University, Minia, Egypt., Hardisty G; Centre for Inflammation Research, University of Edinburgh, Edinburgh EH8 9YL, UK., Lu WY; Centre for Inflammation Research, University of Edinburgh, Edinburgh EH8 9YL, UK., Rantakari P; Institute of Biomedicine, University of Turku, Turku, Finland.; MediCity Research Laboratory, University of Turku, Turku, Finland., Adams DH; Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK., Salmi M; Institute of Biomedicine, University of Turku, Turku, Finland.; MediCity Research Laboratory, University of Turku, Turku, Finland., Hoare M; University of Cambridge, Cancer Research UK Cambridge Institute, Robinson Way, Cambridge CB2 0RE, UK.; University of Cambridge, Department of Medicine, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK., Patten DA; Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.; National Institute for Health Research, Birmingham Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Shetty S; Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.; National Institute for Health Research, Birmingham Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
المصدر: IScience [iScience] 2023 Sep 19; Vol. 26 (10), pp. 107966. Date of Electronic Publication: 2023 Sep 19 (Print Publication: 2023).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: [Cambridge, MA] : Cell Press, [2018]-
مستخلص: Liver sinusoidal endothelial cells (LSEC) undergo significant phenotypic change in chronic liver disease (CLD), and yet the factors that drive this process and the impact on their function as a vascular barrier and gatekeeper for immune cell recruitment are poorly understood. Plasmalemma-vesicle-associated protein (PLVAP) has been characterized as a marker of LSEC in CLD; notably we found that PLVAP upregulation strongly correlated with markers of tissue senescence. Furthermore, exposure of human LSEC to the senescence-associated secretory phenotype (SASP) led to a significant upregulation of PLVAP. Flow-based assays demonstrated that SASP-driven leukocyte recruitment was characterized by paracellular transmigration of monocytes while the majority of lymphocytes migrated transcellularly. Knockdown studies confirmed that PLVAP selectively supported monocyte transmigration mediated through PLVAP's impact on LSEC permeability by regulating phospho-VE-cadherin expression and endothelial gap formation. PLVAP may therefore represent an endothelial target that selectively shapes the senescence-mediated immune microenvironment in liver disease.
Competing Interests: S.S. is a consultant for Faron Pharmaceuticals.
(© 2023 The Author(s).)
References: Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13203-7. (PMID: 10557298)
Blood. 2009 Jul 9;114(2):478-84. (PMID: 19420356)
Cell Mol Gastroenterol Hepatol. 2015 Jul 13;1(5):477-488. (PMID: 28210697)
Front Oncol. 2020 Nov 27;10:589908. (PMID: 33330071)
Nat Cell Biol. 2013 Aug;15(8):978-90. (PMID: 23770676)
Nat Commun. 2016 Jan 27;7:10493. (PMID: 26814335)
Nat Rev Gastroenterol Hepatol. 2018 Sep;15(9):555-567. (PMID: 29844586)
Biochem Biophys Res Commun. 1999 Jan 27;254(3):587-93. (PMID: 9920783)
Sci Transl Med. 2018 Aug 15;10(454):. (PMID: 30111642)
Am J Pathol. 2017 Dec;187(12):2788-2798. (PMID: 29128099)
Elife. 2021 Aug 25;10:. (PMID: 34431475)
Cell. 2020 Oct 15;183(2):377-394.e21. (PMID: 32976798)
Physiol Genomics. 2002 Dec 26;12(1):13-23. (PMID: 12419857)
Liver Transpl. 2001 Nov;7(11):988-97. (PMID: 11699036)
Nat Immunol. 2015 Apr;16(4):386-96. (PMID: 25665101)
Front Physiol. 2020 Aug 28;11:990. (PMID: 32982772)
Nature. 2011 Nov 09;479(7374):547-51. (PMID: 22080947)
J Cell Mol Med. 2019 Feb;23(2):920-933. (PMID: 30394679)
J Hepatol. 2019 Jan;70(1):151-171. (PMID: 30266282)
Hepatology. 1998 Sep;28(3):738-43. (PMID: 9731566)
J Hepatol. 2014 May;60(5):1090-6. (PMID: 24412603)
Clin Liver Dis. 2008 Nov;12(4):861-82, x. (PMID: 18984471)
Gastroenterology. 2009 Feb;136(2):705-14. (PMID: 19010327)
Gut. 2000 Feb;46(2):260-9. (PMID: 10644323)
Genes Dev. 2022 May 1;36(9-10):533-549. (PMID: 35618311)
J Immunol. 2002 Jul 15;169(2):983-92. (PMID: 12097405)
Bioinformatics. 2019 Jun 1;35(12):2084-2092. (PMID: 30395178)
Cancer Cell. 2016 Oct 10;30(4):533-547. (PMID: 27728804)
Histochem Cell Biol. 2012 Nov;138(5):709-24. (PMID: 22782339)
Semin Liver Dis. 2021 Jan;41(1):50-66. (PMID: 33764485)
Nature. 2019 Nov;575(7783):512-518. (PMID: 31597160)
Nat Cell Biol. 2016 Sep;18(9):979-92. (PMID: 27525720)
Biochem Biophys Res Commun. 2020 Jan 29;522(1):240-246. (PMID: 31759628)
Nat Commun. 2018 Mar 9;9(1):1020. (PMID: 29523787)
Am J Physiol Cell Physiol. 2012 Jan 1;302(1):C267-76. (PMID: 22012329)
Hepatology. 2005 Jun;41(6):1262-71. (PMID: 15880761)
J Immunol. 2011 Apr 1;186(7):4147-55. (PMID: 21368224)
Clin Cancer Res. 2005 Nov 1;11(21):7643-50. (PMID: 16278383)
Lab Invest. 1985 Jan;52(1):71-6. (PMID: 3880842)
Am J Pathol. 2011 May;178(5):2121-35. (PMID: 21514427)
Hepatology. 2019 Oct;70(4):1392-1408. (PMID: 30964206)
F1000Res. 2015 Dec 30;4:1521. (PMID: 26925227)
J Pathol. 1991 Jul;164(3):253-9. (PMID: 1890550)
Blood. 2005 Nov 15;106(10):3405-9. (PMID: 16099878)
J Hepatol. 2013 Mar;58(3):549-56. (PMID: 23142622)
Clin Cancer Res. 2019 Feb 1;25(3):912-920. (PMID: 30274981)
Sci Rep. 2017 Dec 14;7(1):17600. (PMID: 29242513)
PLoS Comput Biol. 2019 May 2;15(5):e1006395. (PMID: 31048903)
Mol Biol Cell. 2004 Aug;15(8):3615-30. (PMID: 15155804)
World J Gastroenterol. 2018 Oct 21;24(39):4436-4447. (PMID: 30357021)
Hepatology. 2017 Jan;65(1):294-309. (PMID: 27770554)
Am J Physiol Gastrointest Liver Physiol. 2006 Jul;291(1):G102-9. (PMID: 16565415)
Hepatology. 2012 Oct;56(4):1521-31. (PMID: 22508288)
Dev Cell. 2012 Dec 11;23(6):1203-18. (PMID: 23237953)
J Hepatol. 2014 Oct;61(4):912-24. (PMID: 24911462)
J Pathol. 2005 Aug;206(4):466-75. (PMID: 15971170)
Eur J Pharmacol. 2019 Jul 5;854:240-246. (PMID: 31026444)
J Vis Exp. 2014 Mar 21;(85):. (PMID: 24686418)
Cell Biochem Biophys. 2014 Jun;69(2):283-94. (PMID: 24307281)
Nat Methods. 2017 Apr;14(4):417-419. (PMID: 28263959)
Nature. 2016 Oct 20;538(7625):392-396. (PMID: 27732581)
J Clin Invest. 1989 Oct;84(4):1076-85. (PMID: 2551922)
معلومات مُعتمدة: 26813 United Kingdom CRUK_ Cancer Research UK; MR/R010013/1 United Kingdom MRC_ Medical Research Council; 29959 United Kingdom CRUK_ Cancer Research UK; United Kingdom WT_ Wellcome Trust; MR/X00970X/1 United Kingdom MRC_ Medical Research Council
فهرسة مساهمة: Keywords: Cell biology; Microenvironment; Molecular biology; Omics; Transcriptomics
تواريخ الأحداث: Date Created: 20231009 Latest Revision: 20240320
رمز التحديث: 20240320
مُعرف محوري في PubMed: PMC10558774
DOI: 10.1016/j.isci.2023.107966
PMID: 37810232
قاعدة البيانات: MEDLINE
الوصف
تدمد:2589-0042
DOI:10.1016/j.isci.2023.107966